Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca spins out a bispecific antibody into a new cancer biotech with partner AbPro
AstraZeneca spins out a bispecific antibody into a new cancer biotech with partner AbPro
AstraZeneca spins out a bispecific antibody into a new cancer biotech with partner AbPro
Submitted by
admin
on November 29, 2016 - 9:51am
Source:
Endpoints
News Tags:
AstraZeneca
bispecific antibodies
MedImmune
AbPro
cancer
Headline:
AstraZeneca spins out a bispecific antibody into a new cancer biotech with partner AbPro
Do Not Allow Advertisers to Use My Personal information
